Reuters logo
BRIEF-Concert Pharmaceuticals reports Q3 earnings per share $5.61
2017年11月9日 / 中午12点27分 / 12 天前

BRIEF-Concert Pharmaceuticals reports Q3 earnings per share $5.61

Nov 9 (Reuters) - Concert Pharmaceuticals Inc

* Concert Pharmaceuticals reports third quarter 2017 financial results and provides company update

* Q3 earnings per share $5.61

* Q3 revenue $143.8 million

* Q3 revenue view $11,700 -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S

* Concert Pharmaceuticals Inc - ‍Expects cash, cash equivalents and investments as of September 30, 2017 to be sufficient to fund company into 2021​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below